United States (US) Nucleic Acid Therapeutics CDMO Market (2025-2031) | Analysis, Size & Revenue, Growth, Competitive Landscape, Segmentation, Share, Trends, Value, Companies, Forecast, Industry, Outlook

Market Forecast By Type (Gene Therapy, RNA-based Therapies), By Service (Process Development and Optimization, Manufacturing Services, Analytical and Quality Control Services, Others), By End-user (Pharmaceutical Companies, Government & Academic Research Institutes, Biotech Companies), By Application (Oncology, Genetic Disorders, Infectious Diseases, Others) And Competitive Landscape
Product Code: ETC9971707 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Nucleic Acid Therapeutics CDMO Market Outlook
  • Market Size of United States (US) Nucleic Acid Therapeutics CDMO Market, 2024
  • Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market, 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Revenues & Volume for the Period 2021- 2031
  • United States (US) Nucleic Acid Therapeutics CDMO Market Trend Evolution
  • United States (US) Nucleic Acid Therapeutics CDMO Market Drivers and Challenges
  • United States (US) Nucleic Acid Therapeutics CDMO Price Trends
  • United States (US) Nucleic Acid Therapeutics CDMO Porter's Five Forces
  • United States (US) Nucleic Acid Therapeutics CDMO Industry Life Cycle
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By RNA-based Therapies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Service for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Process Development and Optimization for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Manufacturing Services for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Analytical and Quality Control Services for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Pharmaceutical Companies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Government & Academic Research Institutes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Biotech Companies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Oncology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Genetic Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Nucleic Acid Therapeutics CDMO Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Service
  • Market Opportunity Assessment By End-user
  • Market Opportunity Assessment By Application
  • United States (US) Nucleic Acid Therapeutics CDMO Top Companies Market Share
  • United States (US) Nucleic Acid Therapeutics CDMO Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Nucleic Acid Therapeutics CDMO Company Profiles
  • United States (US) Nucleic Acid Therapeutics CDMO Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6W market outlook report help businesses in making decisions?
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Nucleic Acid Therapeutics CDMO Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Nucleic Acid Therapeutics CDMO Market - Industry Life Cycle

3.4 United States (US) Nucleic Acid Therapeutics CDMO Market - Porter's Five Forces

3.5 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F

3.7 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F

3.8 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F

4 United States (US) Nucleic Acid Therapeutics CDMO Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Nucleic Acid Therapeutics CDMO Market Trends

6 United States (US) Nucleic Acid Therapeutics CDMO Market, By Types

6.1 United States (US) Nucleic Acid Therapeutics CDMO Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.1.4 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By RNA-based Therapies, 2021- 2031F

6.2 United States (US) Nucleic Acid Therapeutics CDMO Market, By Service

6.2.1 Overview and Analysis

6.2.2 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Process Development and Optimization, 2021- 2031F

6.2.3 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Manufacturing Services, 2021- 2031F

6.2.4 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Analytical and Quality Control Services, 2021- 2031F

6.2.5 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Nucleic Acid Therapeutics CDMO Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F

6.3.3 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Government & Academic Research Institutes, 2021- 2031F

6.3.4 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F

6.4 United States (US) Nucleic Acid Therapeutics CDMO Market, By Application

6.4.1 Overview and Analysis

6.4.2 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.4.3 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Genetic Disorders, 2021- 2031F

6.4.4 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.4.5 United States (US) Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Nucleic Acid Therapeutics CDMO Market Import-Export Trade Statistics

7.1 United States (US) Nucleic Acid Therapeutics CDMO Market Export to Major Countries

7.2 United States (US) Nucleic Acid Therapeutics CDMO Market Imports from Major Countries

8 United States (US) Nucleic Acid Therapeutics CDMO Market Key Performance Indicators

9 United States (US) Nucleic Acid Therapeutics CDMO Market - Opportunity Assessment

9.1 United States (US) Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Service, 2021 & 2031F

9.3 United States (US) Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F

9.4 United States (US) Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) Nucleic Acid Therapeutics CDMO Market - Competitive Landscape

10.1 United States (US) Nucleic Acid Therapeutics CDMO Market Revenue Share, By Companies, 2024

10.2 United States (US) Nucleic Acid Therapeutics CDMO Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Related Reports

Industry Events and Analyst Meet

2nd CYBER FIRST QATAR EDITION

2nd CYBER FIRST QATAR EDITION

Truck Trailer and Tyre Expo 2025

Truck Trailer and Tyre Expo 2025

Dairy, Food and Bakery Expo 2025

Dairy, Food and Bakery Expo 2025

Dairy and Food Expo 2025

Dairy and Food Expo 2025

India Green Energy Expo

India Green Energy Expo

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
©2025 6Wresearch, All Right Reserved